VAD

JANS Article

18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context

November 27, 2024 | Aristotle ProtopapasGold Commentor

The opening manuscript on the expected series of American Society of Nuclear Cardiology Imaging Indications. For the cardiovascular surgeon, Tables 2 and 7 offer an update on the use of positron -emission tomography in the...

JANS Article

Analysis of UNOS: Ventricular Assist Device as Bridge-to-Transplant in Paediatric Patients With Congenital Heart Disease

November 13, 2025 | EACTS StaffSilver Contributor

This study analyzed 3,394 pediatric congenital heart disease (CHD) patients listed for heart transplant from 2014 to 2023. Of these, 16.5 percent received ventricular assist device (VAD) support while waitlisted....

JANS Article

18F-FDG PET/CT and Radiolabeled Leukocyte SPECT/CT Imaging for the Evaluation of Cardiovascular Infection in the Multimodality Context

November 27, 2024 | Aristotle ProtopapasGold Commentor

The opening manuscript on the expected series of American Society of Nuclear Cardiology Imaging Indications. For the cardiovascular surgeon, Tables 2 and 7 offer an update on the use of...

JANS Article

Mechanical Circulatory Support in Cardiogenic Shock — Persistence and Progress

May 18, 2024 | Aristotle ProtopapasGold Commentor

This article presents a succinct but comprehensive expert viewpoint on support in cardiogenic shock using the manuscript of the DanGer trial on promising results of Impella in a highly selected...

JANS Article

Value of Invasive Hemodynamic Assessments in Patients Supported by Continuous-Flow Left Ventricular Assist Devices

January 17, 2024 | Jason Trevis

This review explores the application of invasive hemodynamic assessments in the personalization of care for patients with left ventricular assist devices (LVADs). The authors provide a comprehensive approach to their...

JANS Article

Increased Rate of Mortality in Patients Receiving Abiomed Impella RP System

February 5, 2019 | Mark FergusonBronze Contributor

In a letter to healthcare providers, the US FDA summarized a recent evaluation of a postapproval study of the Abiomed Impella RP system. In clinical trials, 73% of patients survived...

JANS Article

Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry

January 30, 2019 | Claire Vernon

Garbade and colleagues compared outcomes reported during the European Conformity (CE) Mark clinical trial of the HeartMate 3 left ventricular assist device (LVAD) to outcomes for patients treated since the...

JANS Article

HeartMate 3 Left Ventricular Assist System Implantation Technique: The Devil is in the Detail

November 30, 2018 | Claire Vernon

Netuka provides several important technical nuances to consider when implanting the HeartMate 3 left heart assist device. He focuses on apical cuff attachment, optimal positioning of the pump in the...

JANS Article

Six-Month Outcomes After Treatment of Advanced Heart Failure With a Full Magnetically Levitated Continuous Flow Left Ventricular Assist Device: Report From the ELEVATE Registry

October 23, 2018 | Wei-Guo Ma

A post-market study (ELEVATE registry) of the fully magnetically levitated continuous flow HeartMate III left ventricular assist device (LVAD) found no pump thrombosis in 463 patients in Europe and Kazakhstan....

JANS Article

Heart Transplant Recipients on Left-Ventricular Assist Device Support at Higher Risk of Primary Graft Dysfunction and Death

October 2, 2018 | Aristotle ProtopapasGold Commentor

Will await the full paper to test the titular preliminary assertion.

...
JANS Article

In Global News: Screening for Congenital Heart Disease, Regenerative Medicine for the Heart, and Predicting Heart Failure Outcomes

June 22, 2018 | Claire Vernon

Patient Care and General Interest Screening infants for critical congenital heart disease at birth is becoming mandatory in the US state of Idaho and the Indian state of Kerala. Tufts...

JANS Article

Reversibility of Severe Mitral Valve Regurgitation After Left Ventricular Assist Device Implantation: Single-Centre Observations From a Real-Life Population of Patients

June 6, 2018 | Claire Vernon

Dobrovie and colleagues performed a retrospective analysis of mitral regurgitation (MR) in 128 patients who had a left ventricular assist device (LVAD) implanted. The authors found that even severe MR...

JANS Article

In Global News: Microbe Resistant Scrubs, LVAD Recall, and Customizing Regenerative Heart Valves

May 25, 2018 | Claire Vernon

Patient Care and General Interest Coal miners in central Appalachia in the US have an increasing incidence of severe black lung disease and an associated increased need for lung transplantation....

LOAD MORE
ADVERTISE ON CTSNET